The identification of the hsa-miR-659-3p/RON and RON/JNK/HIF-2α/MMP12 pathways offer valuable insights into the pathogenesis of bladder cancer and may serve as potential targets for therapeutic interventions in the management of this disease. Here, MST1R is linked to urinary bladder cancer.